Analyst Price Target is $25.33
▲ +2,335.90% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Assure in the last 3 months. The average price target is $25.33, with a high forecast of $60.00 and a low forecast of $4.00. The average price target represents a 2,335.90% upside from the last price of $1.04.
Current Consensus is
The current consensus among 2 polled investment analysts is to buy stock in Assure.
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. The company has operations in Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah, the United States. Assure Holdings Corp. is based in Englewood, Colorado.